| Nanoparticle-Based Drug Delivery | Lifetime | 42 | NZ 1 | 99.75 |
| RNA Interference and Gene Delivery | Lifetime | 84 | NZ 1 | 99.65 |
| Nanoplatforms for cancer theranostics | Lifetime | 90 | NZ 1 | 99.60 |
| Advanced Polymer Synthesis and Characterization | Lifetime | 80 | NZ 1 | 99.36 |
| Advanced biosensing and bioanalysis techniques | Lifetime | 345 | NZ 1 | 99.19 |
| Dendrimers and Hyperbranched Polymers | Lifetime | 46 | NZ 1 | 98.95 |
| Carbon dioxide utilization in catalysis | Lifetime | 207 | NZ 1 | 98.31 |
| Graphene and Nanomaterials Applications | Lifetime | 324 | NZ 1 | 98.04 |
| Polymer Surface Interaction Studies | Lifetime | 269 | NZ 1 | 98.12 |
| biodegradable polymer synthesis and properties | Lifetime | 689 | NZ 3 | 97.73 |
| Antimicrobial agents and applications | Lifetime | 196 | NZ 1 | 94.99 |
| Photopolymerization techniques and applications | Lifetime | 681 | NZ 2 | 92.07 |
| Beetle Biology and Toxicology Studies | Lifetime | 691 | NZ 7 | 51.13 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 10 | NZ 1 | 99.60 |
| RNA Interference and Gene Delivery | 2021-2025 | 25 | NZ 1 | 99.32 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 64 | NZ 1 | 99.52 |
| Antimicrobial Peptides and Activities | 2021-2025 | 63 | NZ 1 | 95.50 |
| Advanced biosensing and bioanalysis techniques | 2021-2025 | 645 | NZ 2 | 96.57 |
| Dendrimers and Hyperbranched Polymers | 2021-2025 | 33 | NZ 1 | 93.61 |
| Immunotherapy and Immune Responses | 2021-2025 | 613 | NZ 1 | 93.41 |
| Antimicrobial agents and applications | 2021-2025 | 75 | NZ 1 | 90.72 |
| Electrospun Nanofibers in Biomedical Applications | 2021-2025 | 761 | NZ 1 | 92.29 |
| Luminescence and Fluorescent Materials | 2021-2025 | 924 | NZ 1 | 92.71 |
| Graphene and Nanomaterials Applications | 2021-2025 | 560 | NZ 1 | 90.48 |
| Photoacoustic and Ultrasonic Imaging | 2021-2025 | 705 | NZ 1 | 86.98 |
| Microfluidic and Capillary Electrophoresis Applications | 2021-2025 | 520 | NZ 1 | 83.20 |
| Cancer Research and Treatments | 2021-2025 | 771 | NZ 3 | 80.58 |
| Cancer therapeutics and mechanisms | 2021-2025 | 790 | NZ 4 | 75.01 |
| Polymer Surface Interaction Studies | 2021-2025 | 702 | NZ 1 | 75.49 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 390 | NZ 1 | 72.11 |
| Protein purification and stability | 2021-2025 | 510 | NZ 1 | 73.04 |
| Adenosine and Purinergic Signaling | 2021-2025 | 556 | NZ 1 | 70.94 |
| Natural Compounds in Disease Treatment | 2021-2025 | 268 | NZ 1 | 39.67 |
